close
close

Apre-salomemanzo

Breaking: Beyond Headlines!

Health of him and hers: far from dead, even with the threat of Amazon to come (NYSE: HIMS)
aecifo

Health of him and hers: far from dead, even with the threat of Amazon to come (NYSE: HIMS)

This article was written by

Profile picture of StockBros Research

I prefer to look for GARP (growth at a reasonable price) stocks but also look for opportunities everywhere else. I don’t have a specific time horizon. I invest in a stock as long as my thesis remains true, and I withdraw when the facts change.

Additionally, I have developed cutting-edge algorithms with Python that have helped me find attractive investment opportunities within my own portfolio, and I have been investing since 2016.

On top of that, I worked at TipRanks as a news analyst/editor and even as an editor for a few years, which not only allowed me to stay on top of the market, but also helped in understanding what people are interested in reading. Additionally, as an editor, I learned to pay attention to details and discovered that there was a lot of misinformation and “fluff” that needed to be corrected. Thus, my goal is to provide accurate and useful information to the best of my ability.

I was previously associated with Investor’s Compass.

Analyst Disclosure: I/we have an advantageous long position in HIMS stock, either through stocks, options or other derivatives. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Request Alpha Disclosure: Past performance does not guarantee future results. No recommendation or advice is given as to whether any investment is suitable for any particular investor. The views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities broker-dealer, investment advisor or investment bank in the United States. Our analysts are third-party authors who include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.